MediPharm Labs Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LABS.TO research report →
Companywww.medipharmlabs.com
MediPharm Labs Corp. , a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
- CEO
- Greg Hunter
- IPO
- 2019
- Employees
- 161
- HQ
- Barrie, ON, CA
Price Chart
Valuation
- Market Cap
- $33.99M
- P/E
- -3.89
- P/S
- 0.79
- P/B
- 0.97
- EV/EBITDA
- -3.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 30.63%
- Op Margin
- -20.37%
- Net Margin
- -20.21%
- ROE
- -23.55%
- ROIC
- -25.10%
Growth & Income
- Revenue
- $45.12M · 7.54%
- Net Income
- $-8,267,000 · 22.69%
- EPS
- $-0.02 · 25.19%
- Op Income
- $-8,408,000
- FCF YoY
- -11.74%
Performance & Tape
- 52W High
- $0.10
- 52W Low
- $0.06
- 50D MA
- $0.07
- 200D MA
- $0.07
- Beta
- 0.96
- Avg Volume
- 311.78K
Get TickerSpark's AI analysis on LABS.TO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LABS.TO Coverage
We haven't published any research on LABS.TO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LABS.TO Report →